ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

All 59 CCOP Awards Announced Heavy In Northeast, Fair In Midwest; Amounts, Priority Scores Listed

June 3, 1983

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

Univ. Officials Propose Conflict Of Interest Guidelines In Report

April 13, 1990

Literature Review Supports Need for More Research In Cancer Control

July 19, 1985

AC To Refuse Government Help In Future Projects

November 24, 1978

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

October 2, 1992